Home

Exchange-Traded Funds

>

First Trust NYSE Arca Biotechnology ETF


Holdings (as at 2026-03-25)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.95%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-03-25)
Security Name % of Net Assets
Moderna, Inc. 5.61%
Gilead Sciences, Inc. 4.10%
United Therapeutics Corporation 4.03%
Amgen Inc. 3.90%
Corcept Therapeutics Inc. 3.88%
Axsome Therapeutics, Inc. 3.76%
Biogen Inc. 3.62%
Sarepta Therapeutics, Inc. 3.59%
Alkermes Plc 3.56%
Vertex Pharmaceuticals Incorporated 3.52%
Krystal Biotech, Inc. 3.51%
Exelixis, Inc. 3.49%
Neurocrine Biosciences, Inc. 3.47%
BioMarin Pharmaceutical Inc. 3.39%
Regeneron Pharmaceuticals, Inc. 3.38%
Illumina, Inc. 3.22%
BioNTech SE (ADR) 3.20%
argenx SE (ADR) 3.18%
Halozyme Therapeutics, Inc. 3.14%
Incyte Corporation 3.10%
Natera, Inc. 3.03%
BeOne Medicines Ltd. (ADR) 3.02%
Alnylam Pharmaceuticals, Inc. 2.97%
ACADIA Pharmaceuticals Inc. 2.95%
Bio-Techne Corporation 2.88%
Veracyte, Inc. 2.80%
Genmab A/S (ADR) 2.74%
Repligen Corporation 2.46%
Bruker Corporation 2.36%
NeoGenomics, Inc. 2.12%
Dreyfus Government Cash Management (Institutional Shares) 0.04%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

FT Portfolios Canada Co.
40 King Street West, Suite 5102, Scotia Plaza, Box 312, Toronto, ON M5H 3Y2 1-877-622-5552
Copyright ©2026 FT Portfolios Canada Co. All Rights Reserved.
  Important Legal Information | Terms of Use | Privacy Policy | Cookie Policy